124 related articles for article (PubMed ID: 7678259)
1. 1 alpha,25-dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin alpha v beta 3.
Medhora MM; Teitelbaum S; Chappel J; Alvarez J; Mimura H; Ross FP; Hruska K
J Biol Chem; 1993 Jan; 268(2):1456-61. PubMed ID: 7678259
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 transcriptionally activates the beta 3-integrin subunit gene in avian osteoclast precursors.
Mimura H; Cao X; Ross FP; Chiba M; Teitelbaum SL
Endocrinology; 1994 Mar; 134(3):1061-6. PubMed ID: 8119143
[TBL] [Abstract][Full Text] [Related]
3. Estrogen enhances alpha v beta 3 integrin expression by avian osteoclast precursors via stabilization of beta 3 integrin mRNA.
Li CF; Ross FP; Cao X; Teitelbaum SL
Mol Endocrinol; 1995 Jul; 9(7):805-13. PubMed ID: 7476964
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes.
Lomri A; Baron R
Proc Natl Acad Sci U S A; 1992 May; 89(10):4688-92. PubMed ID: 1584805
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid stimulates expression of the functional osteoclast integrin alpha v beta 3: transcriptional activation of the beta 3 but not the alpha v gene.
Chiba M; Teitelbaum SL; Cao X; Ross FP
J Cell Biochem; 1996 Sep; 62(4):467-75. PubMed ID: 8891892
[TBL] [Abstract][Full Text] [Related]
6. Phorbol myristate acetate transactivates the avian beta 3 integrin gene and induces alpha v beta 3 integrin expression.
Zhu HJ; Ross FP; Cao X; Teitelbaum SL
J Cell Biochem; 1996 Jun; 61(3):420-9. PubMed ID: 8761946
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha regulates alpha(v)beta5 integrin expression by osteoclast precursors in vitro and in vivo.
Inoue M; Ross FP; Erdmann JM; Abu-Amer Y; Wei S; Teitelbaum SL
Endocrinology; 2000 Jan; 141(1):284-90. PubMed ID: 10614649
[TBL] [Abstract][Full Text] [Related]
9. Regulation of avian calbindin-D28K gene expression in primary chick kidney cells: importance of posttranscriptional mechanisms and calcium ion concentration.
Enomoto H; Hendy GN; Andrews GK; Clemens TL
Endocrinology; 1992 Jun; 130(6):3467-74. PubMed ID: 1375904
[TBL] [Abstract][Full Text] [Related]
10. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
11. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression.
Kim TH; Lee B; Kwon E; Choi CH; Sung IH; Kim Y; Sohn J; Ji JD
Joint Bone Spine; 2013 May; 80(3):307-14. PubMed ID: 23116709
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase.
Chappel J; Ross FP; Abu-Amer Y; Shaw A; Teitelbaum SL
J Cell Biochem; 1997 Dec; 67(4):432-8. PubMed ID: 9383703
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional induction of matrix metalloproteinase-13 (collagenase-3) by 1alpha,25-dihydroxyvitamin D3 in mouse osteoblastic MC3T3-E1 cells.
Uchida M; Shima M; Chikazu D; Fujieda A; Obara K; Suzuki H; Nagai Y; Yamato H; Kawaguchi H
J Bone Miner Res; 2001 Feb; 16(2):221-30. PubMed ID: 11204422
[TBL] [Abstract][Full Text] [Related]
15. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.
Takahashi N; Akatsu T; Sasaki T; Nicholson GC; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Sep; 123(3):1504-10. PubMed ID: 2841098
[TBL] [Abstract][Full Text] [Related]
16. Effect of stem cell factor, interleukin-6, nitric oxide and transforming growth factor-beta on the osteoclast differentiation induced by 1 alpha,25-(OH)2D3 in primary murine bone marrow cultures.
Chae HJ; Park RK; Kang JS; Shin HS; Kim SC; Chung HT; Son DW; Ko KI; Kim JB; Park YC; Kim HR
Pharmacol Toxicol; 1998 May; 82(5):223-9. PubMed ID: 9646327
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of laminin-binding integrins by 1 alpha,25-dihydroxyvitamin D3 in human melanoma cells in vitro.
Hansen CM; Madsen MW; Arensbak B; Skak-Nielsen T; Latini S; Binderup L
Cell Adhes Commun; 1998 Mar; 5(2):109-20. PubMed ID: 9638332
[TBL] [Abstract][Full Text] [Related]
18. Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-dihydroxyvitamin D3.
Cournot G; Petrovic M; Trubert CL; Cormier C; Girault D; Fischer A; Garabedian M
J Bone Miner Res; 1993 Jan; 8(1):61-70. PubMed ID: 7678950
[TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
20. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
